Back
Editas Medicine Stock Predictions
Sponsored
EDIT
Sponsored
NOW is the time to get in on this trillion-dollar megatrend
Get it here.
Sell
37
EDIT
Editas Medicine
Last Price:
5.67
Seasonality Move:
4.23%
7 Day Trial
ALL ACCESS PASS
$
7
This trade could move overnight Thursday!
Access my free presentation on these overnight trades right hereEditas Medicine Stock Forecast
- Over the next 52 weeks, Editas Medicine has on average historically fallen by 10.5% based on the past 8 years of stock performance.
- Editas Medicine has fallen lower in 6 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Editas Medicine Stock Undervalued?
The current Editas Medicine [EDIT] share price is $5.62. The Score for EDIT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal. - EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Editas Medicine Stock Go Up Next Year?
- Over the next 52 weeks, Editas Medicine has on average historically fallen by 10.5% based on the past 8 years of stock performance.
Editas Medicine Stock Rating
Sell
37
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine overpriced?
- Editas Medicine has fallen lower in 6 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Editas Medicine Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
editasmedicine.com
52-Week Data
52-Week High:
11.91
52-Week Low:
5.11
Prediction Charts
Market Cap:
459.79M
Price in USD:
5.62
Volume:
1.34M
Beta:
2.18
Technical Analysis
SMA50:
7.32
SMA100:
8.08
SMA200:
8.25
52-Wk Change:
-28.59%
Stock Predictions
-
Is Editas Medicine stock public?
Yes, Editas Medicine is a publicly traded company. -
What is the Editas Medicine stock quote today?
The Editas Medicine stock price is 5.62 USD today. -
How to buy Editas Medicine stock online?
You can buy Editas Medicine shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-15 | 6.25 | 6.08 | 6.29 | 5.98 |
Apr-16 | 5.98 | 5.85 | 6.03 | 5.85 |
Apr-17 | 5.89 | 5.62 | 5.93 | 5.60 |
Apr-18 | 5.60 | 5.55 | 5.68 | 5.51 |
Apr-19 | 5.52 | 5.50 | 5.68 | 5.29 |
Apr-22 | 5.59 | 5.61 | 5.79 | 5.38 |
Apr-23 | 5.66 | 5.46 | 5.92 | 5.46 |
Apr-24 | 5.51 | 5.35 | 5.59 | 5.28 |
Apr-25 | 5.27 | 5.22 | 5.27 | 5.11 |
Apr-26 | 5.25 | 5.32 | 5.40 | 5.13 |
Apr-29 | 5.38 | 5.37 | 5.55 | 5.30 |
Apr-30 | 5.33 | 5.22 | 5.36 | 5.20 |
May-1 | 5.21 | 5.46 | 5.67 | 5.21 |
May-2 | 5.54 | 5.62 | 5.64 | 5.41 |
Editas Medicine Earnings
Editas Medicine Earnings Report: Per Share Editas Medicine Earnings Q1 Q2 Q3 and Q4 last year and next year.
Editas Medicine Forecast Revenue Growth
Editas Medicine Stock Analysis: Historical quarterly revenues per share for Editas Medicine and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.34 per share, and a decrease next year of $0.17 per share.
* Editas Medicine stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.